Hypertension Competitors

HDII Stock  USD 0.0001  0.00  0.00%   
Analyzing Hypertension Diagnostics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Hypertension Diagnostics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Hypertension Diagnostics Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Hypertension Diagnostics competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000890.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Hypertension Diagnostics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Hypertension Diagnostics and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Hypertension and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Hypertension Diagnostics does not affect the price movement of the other competitor.

High positive correlations

LVCALTGJ
LBWRWRGL
ZCBDTEXG
ASKHWRGL
ZCBDWRGL
EGOCZCBD
  

High negative correlations

TEXGASKH
ZCBDICNM
EGOCASKH
ZCBDASKH
EGOCICNM
EGOCLBWR

Risk-Adjusted Indicators

There is a big difference between Hypertension Pink Sheet performing well and Hypertension Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hypertension Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
WRGL  4.61  2.64  0.00 (0.61) 0.00 
 0.00 
 100.00 
LBWR  6.15  3.65  0.00 (0.41) 0.00 
 0.00 
 200.00 
ASKH  70.46  34.31  0.00 (1.33) 0.00 
 100.00 
 1,095 
ICNM  3.15  1.13  0.00 (0.16) 0.00 
 0.00 
 100.00 
TEXG  0.89  0.52  0.00 (0.41) 0.00 
 0.00 
 28.57 
ZCBD  12.30  6.70  0.00 (0.96) 0.00 
 0.00 
 400.00 
EGOC  39.37  16.63  0.00  5.30  0.00 
 120.00 
 480.00 
LTGJ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
URHG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
LVCA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Hypertension Diagnostics Competitive Analysis

The better you understand Hypertension Diagnostics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Hypertension Diagnostics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Hypertension Diagnostics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
HDII WRGL LBWR ASKH ICNM TEXG ZCBD EGOC LTGJ URHG
 0.00 
 0.0001 
Hypertension
 0.00 
 0.0003 
Warrior
 200.00 
 0.0003 
Labwire
 1,114 
 0.01 
Astika
 0.00 
 0.0002 
Icon
 0.00 
 0.0009 
Terax
 0.00 
 0.0005 
Body
 0.00 
 0.0005 
Energy
 0.00 
 0.0003 
Xiamen
 0.00 
 0.0001 
United
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Z Score
Return On Asset
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio
Value At Risk

Hypertension Diagnostics Competition Performance Charts

Five steps to successful analysis of Hypertension Diagnostics Competition

Hypertension Diagnostics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Hypertension Diagnostics in relation to its competition. Hypertension Diagnostics' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Hypertension Diagnostics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Hypertension Diagnostics' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Hypertension Diagnostics, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Hypertension Diagnostics position

In addition to having Hypertension Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Blockchain Thematic Idea Now

Blockchain
Blockchain Theme
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 28 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Hypertension Pink Sheet

Hypertension Diagnostics financial ratios help investors to determine whether Hypertension Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hypertension with respect to the benefits of owning Hypertension Diagnostics security.